Home Doctors Dr. Pavan Kumar Boyella

    Dr. Pavan Kumar Boyella

    Medical Oncologist


    15+ Years Experience

    Senior Consultant, Oncology : Hemato-oncology

    Jubilee Hills, Hyderabad

    English • Hindi • Telugu • Tamil • Malayalam • Kannada

    -

    Overview
    Education

    Education

    • MBBS (2002–2008): Kasturba Medical College, Mangalore, Karnataka, India – Manipal University
    • MD (Internal Medicine) (2008–2011): J.J.M. Medical College, Davangere, Karnataka, India – Rajiv Gandhi University of Health Sciences
    • DM (Medical Oncology) (2011–2014): Amrita Institute of Medical Sciences, Kochi, Kerala, India – Amrita Vishwa Vidyapeetham

    Fellowships / Observerships

    • One-month observership in Pediatric Oncology and Hematology at Mie University, Tsu City, Mie Prefecture, Japan
    • ECMO Exam – Cleared in September 2014
    Experience

    Clinical Assistant Professor
    Department of Medical Oncology and Hematology, Division of Stem Cell Transplant
    Amrita Institute of Medical Sciences, Ponekkara P.O., Kochi
    September 2014 – October 2015

    Senior Consultant and Lead
    Division of Adult Hematolymphoid Malignancies and Transplant
    Basavatarakam Indo American Cancer Hospital and Research Institute, Road No. 10, Banjara Hills, Hyderabad
    Since January 2016

    Special Interests

    Areas of Expertise

    • Lymphomas
    • Acute Leukemias, MDS, Aplastic Anemia, Multiple Myeloma
    • Stem Cell Transplantation and Cellular Therapies

    Work Achievements

    • Experience of over 700 HSCTs (Haploidentical / MUD / MSD / AUTO) as Consultant
    • Performed 15+ CAR-T cell therapies
    • Achieved the first synchronous ASCT and CAR-T in the country
    Research
    1. W. M. Jose, P. K. Boyella, I. R. Nair, M. Eapen, K. Pavithran (2014). Revisiting Cutaneous Metastasis from Carcinoma Gall Bladder. Indian Journal of Dermatology, Venereology and Leprology, 80(1), 82–85.
    2. Neeraj Sidharthan, Rema Ganapathy, P. Gangadharan, Sumi Soman, Keechilet Pavithran, Raghuveer Prabhu, Haripriya V. Raju, Ayswarya Rajan, Pavankumar Boyella, Rajeswari Arun, Scott C. Howard, Asha Pillai (2015). Strict Treatment Regimen and Febrile Neutropenia Guidelines Allow Favorable Outcomes for Pediatric ALL in Southern India. Blood, 126(23), December 3, 2015.
    3. Sidharthan N., Fuchs E., Unni M., Pavankumar Boyella, et al. (2019). HLA-Mismatched Microtransplantation for Relapsed or Refractory Acute Myeloid Leukemia as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-019-0761-4
    4. Vikram Mathews, Anu Korula, Anupam Chakrapani, Dinesh Bhurani, Jina Bhattacharyya, Manju Sengar, Pankaj Malhotra, Pavan Kumar Boyella, et al. (2023). Management of B-Cell Lineage Acute Lymphoblastic Leukemia: Expert Opinion from an Indian Panel via Delphi Consensus Method. Frontiers in Oncology, 13:1171568.
    5. Sandhya Devi, G. Faiq Ahmed, Manasi C. Mundada, Rachna Khera, Lavanya Nambaru, Krishnamohan Mallavarapu, Pavan Kumar Boyella, Veerandra Patil, Pallavi Suresh Laddha, Senthil J. Rajappa (2022). Retrospective Study of B-Lymphoblastic Leukemia to Assess the Prevalence of TEL/AML1 in South India: A Study of 214 Cases and Review of Literature. Indian Journal of Medical and Paediatric Oncology. DOI: 10.1055/s-0042-1742611
    6. Rachna Khera, Faiq Ahmed, Manasi Mundada, Lavanya Nambaru, Sudha S. Murthy, Sandhya Devi G., Senthil J. Rajappa, Krishna Mohan Mallavarapu, A. Santa, Pavan Kumar Boyella (2018). Acute Myeloid Leukaemia with Gene Mutation: A Correlation with Haematological and Immunophenotypic Characteristics and Our Experience in a Tertiary Care Cancer Center in South India. Turkish Journal of Pathology, 34:171–174.
    7. Manasi Mundada, Faiq Ahmed, Pavan Kumar Boyella, et al. (2023). Histoplasma Infection in a Case of Multiple Myeloma Presenting as a Diagnostic Conundrum. South Asian Journal of Cancer. DOI: 10.1055/s-0043-1761279
    8. Kumar L., Melinkeri S., Ganesan P., Kumar J., Biswas G., Kilara N., Pathalingappa H., Prasad S., Jain M., Mishra S. K., Prasad S., Boyella P. K., Sahoo R. K., Bondarde S., Shah S., Rege M., Deb U., Korde T., Dixit J. (2024). Daratumumab in Indian Patients with Relapsed and Refractory Multiple Myeloma: A Prospective, Multicenter, Phase IV Study. Future Oncology, 20(4):191–205. DOI: 10.2217/fon-2023-0842
    9. Jain H., Karulkar A., Kalra D., Ravikumar S., Shah S., Firfiray A., Pendhari J., Jaiswal A. K., Khan A., Sundharam M., Vaibhaw A., Saroha A., Rajyopadhye S., Basu M., Asija S., Chowdhury A., Beher R., Banik A., Dwivedi A., Purwar S., Narula G., Banavali S., Jain N., Highfill S. L., Stroncek D., Fry T., Melinkeri S., Wilson L., Agarwal N., Aribandi A., Boyella P. K., Shah N. N., Neelapu S. S., Sengar M., Purwar R.; CAR-T Clinical Trial Group (2025). Talicabtagene Autoleucel for Relapsed or Refractory B-Cell Malignancies: Results from an Open-Label, Multicentre, Phase 1/2 Study. The Lancet Haematology, 12(4): e282–e293. DOI: 10.1016/S2352-3026(24)00377-6

    Conference Presentations

    1. B. Pavankumar, K. Pavithran, W. Jose, S. Anita, N. Sidharthan (2013). Low-Dose Rasburicase Is Effective in the Treatment of Adults with Tumor Lysis Syndrome. Presented as a Poster at the Indian Cancer Congress, New Delhi.
    2. R. Pillai, S. Anita, B. Pavan Kumar, W. Jose, K. Pavithran, S. Durgapoorna (2013). Hematological Toxicity Following Treatment with Temozolomide for Gliomas. Presented as a Paper at the Indian Cancer Congress, New Delhi.
    3. M. Jose, P. K. Boyella, N. Krishnan, N. Sidharthan, W. Jose, K. Pavithran (2013). Study of Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP or CHOP. Presented as a Paper at the Indian Cancer Congress, New Delhi.
    4. Neeraj Sidharthan, Rema Ganapathy, P. Gangadharan, Sumi Soman, Keechilet Pavithran, Raghuveer Prabhu, Haripriya V. Raju, Ayswarya Rajan, Pavankumar Boyella, Rajeswari Arun, Scott C. Howard, Asha Pillai (2016). Strict Treatment Regimen and Febrile Neutropenia Guidelines Allow Favorable Outcomes for Pediatric ALL in Southern India. Presented as a Poster at Highlights of ASH Asia Pacific 2016, Brisbane.

    Thesis

    • Ventilator-Associated Pneumonia in ICU (2010) — MD (Internal Medicine)
    • Prognostic Significance of Germinal Center B-Cell and Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphomas Categorized Based on Immunohistochemistry Treated with Immunochemotherapy (2014) — DM (Medical Oncology)

     

     

    Dr. Pavan Kumar Boyella

    Medical Oncologist

    15+ Years Experience

    Senior Consultant, Oncology : Hemato-oncology

    English • Hindi • Telugu • Tamil • Malayalam • Kannada

    -

    -

    Overview
    Education

    Education

    • MBBS (2002–2008): Kasturba Medical College, Mangalore, Karnataka, India – Manipal University
    • MD (Internal Medicine) (2008–2011): J.J.M. Medical College, Davangere, Karnataka, India – Rajiv Gandhi University of Health Sciences
    • DM (Medical Oncology) (2011–2014): Amrita Institute of Medical Sciences, Kochi, Kerala, India – Amrita Vishwa Vidyapeetham

    Fellowships / Observerships

    • One-month observership in Pediatric Oncology and Hematology at Mie University, Tsu City, Mie Prefecture, Japan
    • ECMO Exam – Cleared in September 2014
    Experience

    Clinical Assistant Professor
    Department of Medical Oncology and Hematology, Division of Stem Cell Transplant
    Amrita Institute of Medical Sciences, Ponekkara P.O., Kochi
    September 2014 – October 2015

    Senior Consultant and Lead
    Division of Adult Hematolymphoid Malignancies and Transplant
    Basavatarakam Indo American Cancer Hospital and Research Institute, Road No. 10, Banjara Hills, Hyderabad
    Since January 2016

    Special Interests

    Areas of Expertise

    • Lymphomas
    • Acute Leukemias, MDS, Aplastic Anemia, Multiple Myeloma
    • Stem Cell Transplantation and Cellular Therapies

    Work Achievements

    • Experience of over 700 HSCTs (Haploidentical / MUD / MSD / AUTO) as Consultant
    • Performed 15+ CAR-T cell therapies
    • Achieved the first synchronous ASCT and CAR-T in the country
    Research
    1. W. M. Jose, P. K. Boyella, I. R. Nair, M. Eapen, K. Pavithran (2014). Revisiting Cutaneous Metastasis from Carcinoma Gall Bladder. Indian Journal of Dermatology, Venereology and Leprology, 80(1), 82–85.
    2. Neeraj Sidharthan, Rema Ganapathy, P. Gangadharan, Sumi Soman, Keechilet Pavithran, Raghuveer Prabhu, Haripriya V. Raju, Ayswarya Rajan, Pavankumar Boyella, Rajeswari Arun, Scott C. Howard, Asha Pillai (2015). Strict Treatment Regimen and Febrile Neutropenia Guidelines Allow Favorable Outcomes for Pediatric ALL in Southern India. Blood, 126(23), December 3, 2015.
    3. Sidharthan N., Fuchs E., Unni M., Pavankumar Boyella, et al. (2019). HLA-Mismatched Microtransplantation for Relapsed or Refractory Acute Myeloid Leukemia as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-019-0761-4
    4. Vikram Mathews, Anu Korula, Anupam Chakrapani, Dinesh Bhurani, Jina Bhattacharyya, Manju Sengar, Pankaj Malhotra, Pavan Kumar Boyella, et al. (2023). Management of B-Cell Lineage Acute Lymphoblastic Leukemia: Expert Opinion from an Indian Panel via Delphi Consensus Method. Frontiers in Oncology, 13:1171568.
    5. Sandhya Devi, G. Faiq Ahmed, Manasi C. Mundada, Rachna Khera, Lavanya Nambaru, Krishnamohan Mallavarapu, Pavan Kumar Boyella, Veerandra Patil, Pallavi Suresh Laddha, Senthil J. Rajappa (2022). Retrospective Study of B-Lymphoblastic Leukemia to Assess the Prevalence of TEL/AML1 in South India: A Study of 214 Cases and Review of Literature. Indian Journal of Medical and Paediatric Oncology. DOI: 10.1055/s-0042-1742611
    6. Rachna Khera, Faiq Ahmed, Manasi Mundada, Lavanya Nambaru, Sudha S. Murthy, Sandhya Devi G., Senthil J. Rajappa, Krishna Mohan Mallavarapu, A. Santa, Pavan Kumar Boyella (2018). Acute Myeloid Leukaemia with Gene Mutation: A Correlation with Haematological and Immunophenotypic Characteristics and Our Experience in a Tertiary Care Cancer Center in South India. Turkish Journal of Pathology, 34:171–174.
    7. Manasi Mundada, Faiq Ahmed, Pavan Kumar Boyella, et al. (2023). Histoplasma Infection in a Case of Multiple Myeloma Presenting as a Diagnostic Conundrum. South Asian Journal of Cancer. DOI: 10.1055/s-0043-1761279
    8. Kumar L., Melinkeri S., Ganesan P., Kumar J., Biswas G., Kilara N., Pathalingappa H., Prasad S., Jain M., Mishra S. K., Prasad S., Boyella P. K., Sahoo R. K., Bondarde S., Shah S., Rege M., Deb U., Korde T., Dixit J. (2024). Daratumumab in Indian Patients with Relapsed and Refractory Multiple Myeloma: A Prospective, Multicenter, Phase IV Study. Future Oncology, 20(4):191–205. DOI: 10.2217/fon-2023-0842
    9. Jain H., Karulkar A., Kalra D., Ravikumar S., Shah S., Firfiray A., Pendhari J., Jaiswal A. K., Khan A., Sundharam M., Vaibhaw A., Saroha A., Rajyopadhye S., Basu M., Asija S., Chowdhury A., Beher R., Banik A., Dwivedi A., Purwar S., Narula G., Banavali S., Jain N., Highfill S. L., Stroncek D., Fry T., Melinkeri S., Wilson L., Agarwal N., Aribandi A., Boyella P. K., Shah N. N., Neelapu S. S., Sengar M., Purwar R.; CAR-T Clinical Trial Group (2025). Talicabtagene Autoleucel for Relapsed or Refractory B-Cell Malignancies: Results from an Open-Label, Multicentre, Phase 1/2 Study. The Lancet Haematology, 12(4): e282–e293. DOI: 10.1016/S2352-3026(24)00377-6

    Conference Presentations

    1. B. Pavankumar, K. Pavithran, W. Jose, S. Anita, N. Sidharthan (2013). Low-Dose Rasburicase Is Effective in the Treatment of Adults with Tumor Lysis Syndrome. Presented as a Poster at the Indian Cancer Congress, New Delhi.
    2. R. Pillai, S. Anita, B. Pavan Kumar, W. Jose, K. Pavithran, S. Durgapoorna (2013). Hematological Toxicity Following Treatment with Temozolomide for Gliomas. Presented as a Paper at the Indian Cancer Congress, New Delhi.
    3. M. Jose, P. K. Boyella, N. Krishnan, N. Sidharthan, W. Jose, K. Pavithran (2013). Study of Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP or CHOP. Presented as a Paper at the Indian Cancer Congress, New Delhi.
    4. Neeraj Sidharthan, Rema Ganapathy, P. Gangadharan, Sumi Soman, Keechilet Pavithran, Raghuveer Prabhu, Haripriya V. Raju, Ayswarya Rajan, Pavankumar Boyella, Rajeswari Arun, Scott C. Howard, Asha Pillai (2016). Strict Treatment Regimen and Febrile Neutropenia Guidelines Allow Favorable Outcomes for Pediatric ALL in Southern India. Presented as a Poster at Highlights of ASH Asia Pacific 2016, Brisbane.

    Thesis

    • Ventilator-Associated Pneumonia in ICU (2010) — MD (Internal Medicine)
    • Prognostic Significance of Germinal Center B-Cell and Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphomas Categorized Based on Immunohistochemistry Treated with Immunochemotherapy (2014) — DM (Medical Oncology)

     

     

    '
    Book ProHealth Book Appointment

    Request A Call Back

    Close
    © Copyright 2026. Apollo Hospitals Group. All Rights Reserved.
    phone 040-69321000 Book Health Check-up Book Health Check-up Book Appointment

    Request A Call Back

    Close